EDITAS MEDICINE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.67 USD | -1.48% |
|
-8.61% | -53.90% |
Chart calendar Editas Medicine, Inc.
759f57f9f6d18a966.8AFMojURI7K8KOHC3twQm3Pt5aHnjMomZGT-CkAftQ8.n2c--gUlQOeEZauDhJ9V2QOUp8Kr6axWMgmbWhcu0Wq3Zz_Ef3Nu-_t4ig~8855bf84d900d5ccb8901bdf80d41c97
Upcoming events on Editas Medicine, Inc.
Past events on Editas Medicine, Inc.
| 15/06/2024 10:30 | European Hematology Association Meeting - Rabi Hanna |
| 14/06/2024 15:00 | European Hematology Association Meeting - Haydar Frangoul |
| 30/05/2024 13:30 | Annual General Meeting |
| 27/05/2024 | Stifel Genetic Medicines Forum |
| 15/05/2024 19:05 | RBC Capital Markets Global Healthcare Conference |
| 13/05/2024 | Bank of America Securities Health Care Conference |
| 10/05/2024 21:00 | American Society of Gene & Cell Therapy Meeting - Abstract Number: 276 |
| 10/05/2024 20:45 | American Society of Gene & Cell Therapy Meeting - Abstract Number: 276 |
| 10/05/2024 17:00 | American Society of Gene & Cell Therapy Meeting - Abstract Number: 1681 |
| 09/05/2024 17:00 | American Society of Gene & Cell Therapy Meeting - Abstract Number: 1182 |
| 08/05/2024 13:00 | Q1 2024 Earnings Call |
| 08/05/2024 12:00 | Q1 2024 Earnings Release |
| 06/05/2024 | American Society of Gene & Cell Therapy Meeting |
| 13/03/2024 18:05 | Barclays Global Healthcare Conference |
| 12/03/2024 14:40 | Leerink Partners Global Biopharma Conference |
| 04/03/2024 17:50 | TD Cowen Health Care Conference |
| 28/02/2024 13:00 | Q4 2023 Earnings Call |
| 28/02/2024 12:00 | Q4 2023 Earnings Release |
| 13/02/2024 13:40 | Oppenheimer Healthcare Life Sciences Conference - Fireside Chat |
| 07/02/2024 14:30 | Guggenheim Healthcare Talks Biotechnology Conference - Fireside Chat |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 20,5 56,1 -63.41% | 90,7 84,7 7.14% | 25,5 17,4 46.55% | 19,7 16,6 18.7% | 78,1 33,8 131.08% | 28,8 |
|
EBITDA Million USD | Released Forecast Spread | -138 -58,5 -136.01% | -131 -101 -29.63% | -188 -211 10.67% | -220 -204 -7.67% | -163 -167 2.61% | -244 |
|
EBIT Million USD | Released Forecast Spread | -141 -98,4 -43.22% | -135 -118 -14.37% | -193 -207 6.53% | -226 -218 -3.75% | -169 -193 12.16% | -246 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -134 -86,6 -54.43% | -116 -102 -13.49% | -193 -206 6.43% | -220 -215 -2.34% | -153 -184 16.76% | -226 |
|
Net income Million USD | Released Forecast Spread | -134 -92,1 -45.19% | -116 -102 -13.51% | -193 -207 6.79% | -220 -215 -2.55% | -153 -173 11.6% | -225 |
|
EPS USD | Released Forecast Spread | -2,68 -1,86 -44.44% | -1,98 -1,94 -1.86% | -2,85 -3,05 6.61% | -3,21 -3,13 -2.6% | -2,02 -2,26 10.44% | -2,63 |
| Announcement Date | 26/02/20 | 25/02/21 | 24/02/22 | 22/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6,77 3,85 75.75% | 6,36 4,29 48.27% | 0,04 5,12 -99.18% | 6,54 3,76 73.87% | 9,85 3,29 199.87% | 2,89 4,39 -34.23% | 5,34 3,42 56.08% | 60,0 14,3 319.61% | 1,14 7,30 -84.44% | 4,14 | 6,29 | 14,4 | 5,03 | 5,03 |
|
EBITDA Million USD | Released Forecast Spread | -50,8 -52,0 2.4% | -61,9 -41,0 -50.94% | -48,6 -43,0 -13.14% | -22,5 -10,9 -107.04% | -65,6 -60,5 -8.47% | -65,4 | -66,6 | -57,8 | ||||||
|
EBIT Million USD | Released Forecast Spread | -50,8 -56,3 9.92% | -54,2 -57,0 4.81% | -57,5 -60,5 4.92% | -63,4 -56,7 -11.88% | -51,0 -57,2 10.97% | -44,1 -56,0 21.29% | -50,2 -47,1 -6.42% | -24,0 -47,4 49.45% | -67,0 -55,8 -20.13% | -61,1 | -59,8 | -58,0 | -60,9 | -63,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -50,5 -56,6 10.7% | -53,5 -56,5 5.45% | -55,7 -59,8 6.74% | -60,7 -55,7 -9.08% | -49,0 -53,8 8.82% | -40,3 -53,4 24.58% | -45,0 -42,8 -5.27% | -18,9 -49,7 62.03% | -62,0 -45,2 -37.16% | -55,8 | -54,3 | -53,7 | -58,7 | -60,5 |
|
Net income Million USD | Released Forecast Spread | -50,5 -57,3 11.84% | -53,5 -57,2 6.52% | -55,7 -60,6 8.12% | -60,7 -56,1 -8.36% | -49,0 -54,3 9.68% | -40,3 -53,9 25.2% | -45,0 -44,4 -1.33% | -18,9 -39,0 51.57% | -62,0 -46,7 -32.59% | -55,9 | -54,8 | -52,6 | -58,7 | -60,5 |
|
EPS USD | Released Forecast Spread | -0,74 -0,81 8.45% | -0,78 -0,84 6.7% | -0,81 -0,88 8.09% | -0,88 -0,80 -9.44% | -0,71 -0,79 9.92% | -0,56 -0,77 27.31% | -0,55 -0,57 3.47% | -0,23 -0,46 50.5% | -0,76 -0,58 -31.42% | -0,68 | -0,67 | -0,58 | -0,64 | -0,64 |
| Announcement Date | 04/05/22 | 03/08/22 | 02/11/22 | 22/02/23 | 05/05/23 | 02/08/23 | 03/11/23 | 28/02/24 | 08/05/24 | - | - | - | - | - |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Editas Medicine, Inc.
| 07/06/2024 07:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EDIT Stock
- Calendar Editas Medicine, Inc.
